fulvestrant

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 129453-61-8

Where It Comes From

33 FDA-registered drug labelers
Accord Healthcare Inc.
Alembic Pharmaceuticals Inc.
Amneal Pharmaceuticals LLC
AstraZeneca Pharmaceuticals LP
Athenex Pharmaceutical Division, LLC.
Avenacy, Inc.
BluePoint Laboratories
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Dr.Reddy's Laboratories Inc
Eugia US LLC
Farmabios S.p.A.
Fresenius Kabi USA, LLC
GLENMARK PHARMACEUTICALS INC., USA
Hikma Pharmaceuticals USA Inc.
Industriale Chimica s.r.l.
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Lianyungang Runzhong Pharmaceutical Co. Ltd.
Meitheal Pharmaceuticals Inc
Minakem High Potent SA
N.V. Ajinomoto Omnichem S.A.
Northstar Rx, LLC,
Sagent Pharmaceuticals
Sandoz Inc
ScinoPharm Taiwan Ltd.
Sicor S.r.l.
Sinopep-Allsino Biopharmaceutical Co., Ltd.
Sterling Chemical Malta Ltd
STERLING SPA
Steroid S.p.A.
Wavelength Enterprises LTD
Xiromed, LLC
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 2 drug and cosmetic product listings (FDA).

  • fulvestrant
  • Faslodex
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS129453-61-8
PubChem CID104741
DTXSIDDTXSID4022369
FormulaC32H47F5O3S
Mol. Weight606.8 g/mol
SMILESCC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F

Data Sources

1047412026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/fulvestrant/cids/JSON

Archive: data/sources/pubchem_name/fulvestrant.json

CAS 129453-61-82026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

bulk match2026-04-07

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json